Free Trial

GM Advisory Group LLC Lowers Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

HealthEquity logo with Medical background
Remove Ads

GM Advisory Group LLC lowered its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 5.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 83,757 shares of the company's stock after selling 5,256 shares during the quarter. GM Advisory Group LLC owned about 0.10% of HealthEquity worth $8,036,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Arcadia Investment Management Corp MI purchased a new stake in shares of HealthEquity in the fourth quarter worth approximately $26,000. Smartleaf Asset Management LLC grew its holdings in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after buying an additional 98 shares in the last quarter. Proficio Capital Partners LLC purchased a new stake in HealthEquity in the 4th quarter valued at $39,000. UMB Bank n.a. raised its position in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after buying an additional 164 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ lifted its stake in HealthEquity by 1,934.8% during the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after acquiring an additional 445 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.20% of the stock is currently owned by company insiders.

Remove Ads

HealthEquity Stock Performance

Shares of NASDAQ HQY traded up $0.28 during trading on Friday, reaching $84.88. 1,740,588 shares of the stock traded hands, compared to its average volume of 693,931. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock has a market capitalization of $7.36 billion, a P/E ratio of 77.87, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a 50-day moving average of $104.90 and a 200-day moving average of $95.67.

Analyst Upgrades and Downgrades

HQY has been the subject of several analyst reports. Royal Bank of Canada increased their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a report on Tuesday, December 10th. Mizuho assumed coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price objective for the company. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Tuesday, December 10th. Barrington Research reaffirmed an "outperform" rating and issued a $112.00 target price on shares of HealthEquity in a report on Friday, March 14th. Finally, Wells Fargo & Company lifted their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $112.92.

Get Our Latest Stock Report on HQY

About HealthEquity

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Stories

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads